Connect to other sites within the UBM Medica Network
Effect of Metformin on RCC Survival Warrants Further Study
Patient exposure to metformin before undergoing nephrectomy for renal cell carcinoma may have an effect on patient survival, according to a new study.
Androgen Deprivation Therapy in Localized Prostate Cancer
Following studies that found no survival or mortality benefit, we discuss the utility of primary androgen deprivation therapy in localized prostate cancer.
Natural Killer Cells Could Fight Off ALL
A laboratory study found that natural killer cells could be multiplied from the blood of patients to fight off precursor B-lineage acute lymphoblastic leukemia.
10 Must-Read Books for Oncologists and Science Enthusiasts
We present an end-of-summer list of must-reads, covering everything from the history of cancer to environmental destruction to the upcoming sixth extinction.
Simple Tool Predicts Survival in Advanced Cancer
Using a simple tool to measure performance status can help physicians predict survival and facilitate end-of-life planning in outpatients with advanced cancer.
Technique Reduces Colorectal Surgery Infections
A systematic, best-practice approach to colorectal surgery can decrease the risk of surgical site infections, according to a new study.
Robot-Assisted Prostate Cancer Surgery on the Rise
The adoption of robot-assisted radical prostatectomy is on the rise in the United States, according to the results of a retrospective study.
I’m Tired! Is There a Pill for That?
When someone states they are “tired,” it prompts follow-up questions regarding activity, sleep, diet, and stress, among other things—just as a complaint of pain leads to where, what kind, and how long.
Characteristics Linked to High-Mitotic-Rate Melanoma Identified
Researchers identified characteristics that may be associated with high-mitotic-rate tumors--being male, elderly, and having a history of solar field damage.
MicroRNA Expression Predictive of Outcomes in Esophageal Cancer
Measuring expression of several microRNAs were significantly predictive of complete pathologic response to treatment in patients with esophageal adenocarcinoma.
By clicking Accept, you agree to become a member of the UBM Medica Community.